loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 203168 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BROMFENAC SODIUM (1)

filter

01 BAUSCH AND LOMB (1)

filter

01 SOLUTION/DROPS;OPHTHALMIC (1)

filter

01 EQ 0.07% ACID (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION/DROPS;OPHTHAL...
EQ 0.07% ACID
PROLENSA
USA
203168
2013-04-05
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203168

Looking for CTD TGA MCC DOSSIER APPLICATION 203168 1

19

Bausch & Lomb Incorporated, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is BROMFENAC SODIUM, with a corresponding application number 203168 and regulatory information .

proudly manufactured in the

approval since 2013-04-05

Bausch & Lomb Incorporated's PROLENSA SOLUTION/DROPS;OPHTHALMIC, medication with EQ 0.07% ACID of BROMFENAC SODIUM.

Post Enquiry
POST ENQUIRY